PHARMACEUTICAL

Pharmaceutical Trading Platform Yaoshibang Applies for Hong Kong IPO

Yaoshibang, a Chinese pharmaceutical distribution platform, submitted an application on Tuesday for a public listing to the Hong Kong Stock Exchange (HKEx), with Goldman Sachs and CICC named as co-sponsors.

Triastek Reaps Millions in B+ Round of Financing, Led By Triwise Capital

On Tuesday, Chinese 3D printing pharmaceutical company Triastek announced the completion of several hundred million yuan in a B+ round of financing.

Sinotau Pharmaceutical Group Completes $50 Million D+ Round of Financing with Focus on Radiopharmaceutical R&D

Sinotau Pharmaceutical Group announced in a document on Thursday that it has completed a D+ round of financing worth 320 million yuan ($50.03 million). The funds raised are for clinical R&D of new radioactive drugs.

The New Miracle Cure in Town: Behind the Hype for Pien Tze Huang

The sun is scorching every corner of China with summer heat at the moment, yet a Traditional Chinese Medicine (TCM) product called Pien Tze Huang (PTH) has sparked even more heated discussion across Chinese media. Sold at 590 yuan (about $90) for just one 3-gram pill, with customers craving more, PTH is the unabashed hottest star in the Chinese pharmaceutical market for the first half of this year. In this piece we zoom in on the tiny magic pill to find out what power is contained therein and what is behind the frenzy.

China VC Weekly: E-sports, Autonomous Driving and More

Last week’s biggest VC fundraising announcements included the 180 million yuan investment raised by Bilibili E-sports, WeRide’s $310 million Series C, VISEN Pharmaceuticals' $150 million Series B, and the latest $46 million round raised by robot-maker Jaka.

Everything about China's Innovation